Heparin-induced thrombocytopenia

Expert Review of Cardiovascular Therapy
Beng H Chong, James J H Chong

Abstract

Heparin is widely used for the prevention and treatment of thrombotic and particularly cardiovascular disorders. Unfortunately, 0.5 to 3.0% of patients given heparin develop an immune reaction, commonly termed Type II heparin-induced thrombocytopenia (HIT). This is characterized by a moderate thrombocytopenia and in some patients, a venous or arterial thrombosis. This frequently leads to disastrous sequelae, such as limb amputation and death. The pathophysiological basis of this serious adverse drug reaction is the production of an immunoglobulin G antibody that reacts with an antigenic complex consisting of heparin and platelet factor 4. A significant risk factor for the development of HIT is recent surgery, and the frequency of developing an antiheparin-platelet factor 4 or HIT antibody is particularly high in cardiac surgery patients, although surprisingly, only a few of these patients actually develop the clinical syndrome of HIT. This review will discuss the frequency, pathophysiology, clinical features, diagnosis and management of HIT.

Associated Clinical Trials

References

May 1, 1990·The Annals of Thoracic Surgery·J R KappaV P Addonizio
Mar 1, 1990·British Journal of Haematology·M K Horne, E S Chao
Sep 1, 1989·European Journal of Haematology·B H Chong, F Ismail
Mar 5, 1987·The New England Journal of Medicine·D B CinesS Tannenbaum
Dec 1, 1985·European Journal of Clinical Investigation·D P MikhailidisP Dandona
Sep 1, 1985·Archives of Internal Medicine·J I CohenC S Greenberg
Jul 1, 1982·Thrombosis Research·J DawesD S Pepper
Oct 16, 1980·The New England Journal of Medicine·W R Bell, R M Royall
Dec 1, 1981·British Journal of Haematology·B H ChongM C Rozenberg
Sep 1, 1995·British Journal of Haematology·M W StewartP A Gordon
Mar 1, 1995·British Journal of Haematology·B H Chong
Feb 12, 1998·Annals of Internal Medicine·T E WarkentinJ G Kelton
Mar 1, 1997·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·J AmiralD Meyer
Jul 23, 1998·British Journal of Haematology·M TrossaërtE Fressinaud
Dec 3, 1999·British Journal of Haematology·P M Newman, B H Chong
Nov 18, 2000·Archives of Pathology & Laboratory Medicine·F FabrisJ Fareed
Apr 11, 2001·Circulation·B E LewisUNKNOWN ARG-911 Study Investigators
Nov 13, 2001·Reviews in Clinical and Experimental Hematology·A GreinacherV Kiefel
Jun 28, 2002·Clinical Pharmacology and Therapeutics·Richard RobsonChristopher Frampton
Oct 3, 2002·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Bruce E LewisUNKNOWN ARG-216/310/311 Study Investigators
Aug 13, 2003·Archives of Internal Medicine·Bruce E LewisUNKNOWN Argatroban-915 Investigators
Aug 15, 2003·The New England Journal of Medicine·Harry R Büller, Martin H Prins
Dec 5, 2003·Lancet·Gunnar O OlssonAlex Gold
Mar 3, 2004·The Annals of Thoracic Surgery·Alan F MerryHarvey D White
Jan 1, 2004·Tobacco Induced Diseases·Meir GorskyNoam Yarom

❮ Previous
Next ❯

Citations

May 20, 2006·Thrombosis Research·Lorenz RischMarkus Schmugge
Mar 27, 2007·Pharmacotherapy·William E DagerMaureen A Smythe
Jul 13, 2013·Blood·Beng H Chong, James J-H Chong
Feb 28, 2008·The Annals of Pharmacotherapy·William E Dager
Apr 4, 2012·Phlebology·R S FigueiredoV Bhattacharya
Apr 21, 2010·Journal of Thrombosis and Haemostasis : JTH·T E Warkentin, L-A Linkins
Sep 6, 2012·Journal of Thrombosis and Haemostasis : JTH·T E WarkentinUNKNOWN scientific and standardization committee of the international society on thrombosis and haemostasis
Jul 1, 2020·Platelets·Genevieve MarcouxEric Boilard
Nov 3, 2012·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Niyati H VakilJennifer L Donovan
Jan 3, 2021·Journal of Thrombosis and Thrombolysis·Zeina Marashi-SabouniLaurence Camoin-Jau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Medsurg Nursing : Official Journal of the Academy of Medical-Surgical Nurses
K Conley, M Letizia
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Lisa A HouriganG William Dec
Recenti progressi in medicina
Massimo Franchini, Dino Veneri
Journal of Pharmacy Practice
Jennifer L DonovanAbir O Kanaan
© 2022 Meta ULC. All rights reserved